Wed, February 4, 2009
[ Wed, Feb 04th 2009 ] - Market Wire
Toxin Alert Inc.: Andersen Resigns From Toxin Alert Board
[ Wed, Feb 04th 2009 ] - Market Wire
Inhibitex to Present at the 11th Annual BIO CEO & Investor Conference
[ Wed, Feb 04th 2009 ] - Market Wire
Oragenics, Inc. annonce un accord avec Garden of Life Inc. pour l'usage de ProBiora3
[ Wed, Feb 04th 2009 ] - Market Wire
Urigen Pharmaceuticals: Urigen Announces Recent Insider Purchases Total Over 500,000 Shares
[ Wed, Feb 04th 2009 ] - Market Wire
Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of
[ Wed, Feb 04th 2009 ] - Market Wire
Helicos Announces Improved Performance of Its Hel .. pe" Single Molecule Sequencer and tSMS" Chemistry
[ Wed, Feb 04th 2009 ] - Market Wire
Biofield Corp. Expands Arsenal Of Non-Invasive Diagnostic Devices
[ Wed, Feb 04th 2009 ] - Market Wire
Bio-Imaging Technologies to Release Fourth Quarte .. Results and Host Conference Call on February 11,
[ Wed, Feb 04th 2009 ] - Market Wire
Oragenics, Inc., Announces Agreement with Garden of Life, Inc., for Use of ProBiora3
[ Wed, Feb 04th 2009 ] - Market Wire
Progenics Appoints Peter J. Crowley as Independent Board Member
[ Wed, Feb 04th 2009 ] - Market Wire
UnitedHealth Group Makes It Simpler for Physician .. nister Health Care with Updated Customer ID Cards
[ Wed, Feb 04th 2009 ] - Market Wire
EXACT Sciences Announces Issuance of Key Patent C .. ing Vimentin Gene for Colorectal Cancer Screening
[ Wed, Feb 04th 2009 ] - Market Wire
Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System
[ Wed, Feb 04th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter and Full Year 2008 Results and Conduct Conf
[ Wed, Feb 04th 2009 ] - Market Wire
MEDNAX, Inc. Acquires Neonatal Practice
[ Wed, Feb 04th 2009 ] - Market Wire
Compugen Ltd. to Review Fourth Quarter and Year-E .. Financial Results on Wednesday, February 11, 2009
[ Wed, Feb 04th 2009 ] - Market Wire
Sequenom to Hold Fourth Quarter and Full Year 200 .. Financial Results Conference Call on February 11
[ Wed, Feb 04th 2009 ] - Market Wire
Xenomics, Inc. Restructures and Extends Maturity of Convertible Debentures
Tue, February 3, 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
Community Health Systems to Participate in the 2009 UBS Global Healthcare Services Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment
[ Tue, Feb 03rd 2009 ] - Market Wire
ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
Response Genetics Signs Agreement With Roche Diagnostics to Support Cancer Test Development
[ Tue, Feb 03rd 2009 ] - Market Wire
Affymax to Present at BIO CEO and Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses
[ Tue, Feb 03rd 2009 ] - Market Wire
PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.
[ Tue, Feb 03rd 2009 ] - Market Wire
Myriad Genetics: Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM
[ Tue, Feb 03rd 2009 ] - Market Wire
Amarin to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Reflect Scientific: $400,000 Order for Newly Rele .. 7000 System Received by Reflect Scientific, Inc.
[ Tue, Feb 03rd 2009 ] - Market Wire
Acorda Therapeutics to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Amedisys Acquires Two Home Health Agencies in Arizona
[ Tue, Feb 03rd 2009 ] - Market Wire
GTx Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
CeragenixAchieves 120 Daysof Antimicrobial Efficacy on Treated Silicone Medical Device.
[ Tue, Feb 03rd 2009 ] - Market Wire
Inspire Announces Webcast of Presentation at BIO CEO Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Compugen Announces Discovery of Biomarker Candida .. ian Cancer and Signing of Collaboration Agreement
[ Tue, Feb 03rd 2009 ] - Market Wire
Endologix to Hold 2008 Fourth Quarter and Full Ye .. Financial Results Conference Call on February 19
Mon, February 2, 2009
[ Mon, Feb 02nd 2009 ] - Market Wire
Kindred Healthcare to Present at the UBS Global Healthcare Services Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
LHC Group and Ochsner Health System Complete Home Health Joint Venture
[ Mon, Feb 02nd 2009 ] - Market Wire
Corcept Therapeutics: CORLUX(R) Mitigates Weight .. al(R), Expands on Proof of Concept Established in
[ Mon, Feb 02nd 2009 ] - Market Wire
Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study
[ Mon, Feb 02nd 2009 ] - Market Wire
Wright Medical Group, Inc. to Host Fourth Quarter 2008 Earnings Conference Call
[ Mon, Feb 02nd 2009 ] - Market Wire
Allos Therapeutics to Present at the 2009 BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Aetna Awarded $600,000 to Non-Profits in Maryland, Virginia and the District of Columbia
[ Mon, Feb 02nd 2009 ] - Market Wire
ZIOPHARM Oncology to Present at the 11th Annual BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Synta Completes Enrollment of the Phase 3 SYMMETR .. ial of Elesclomol in Stage IV Metastatic Melanoma
[ Mon, Feb 02nd 2009 ] - Market Wire
Community Health Systems, Inc. Announces the Acquisition of Siloam Springs, Arkansas Hospital
[ Mon, Feb 02nd 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. llment in Phase IIb Clinical Trial of XIAFLEX(TM)
[ Mon, Feb 02nd 2009 ] - Market Wire
Ceragenix and Hyphens Enter Into Distribution and Supply Agreement for EpiCeram®
[ Mon, Feb 02nd 2009 ] - Market Wire
Idera Pharmaceuticals Announces Achievement of Cl .. ollaboration with Merck KGaA for Cancer Treatment
[ Mon, Feb 02nd 2009 ] - Market Wire
Acorda Therapeutics Submits New Drug Application .. ment of Walking Ability in People with Multiple S
[ Mon, Feb 02nd 2009 ] - Market Wire
LifePoint Hospitals Acquires Rockdale Medical Center
[ Mon, Feb 02nd 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. icals to Present at BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in
[ Mon, Feb 02nd 2009 ] - Market Wire
ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results
Sun, February 1, 2009
[ Sun, Feb 01st 2009 ] - Market Wire
FORTIS: Fortis holding announcement
Sat, January 31, 2009
[ Sat, Jan 31st 2009 ] - Market Wire
FORTIS: Fortis holding publishes addendum to shareholder circular
[ Sat, Jan 31st 2009 ] - Market Wire
Resumen: REVLIMID® recibe recomendacin prelimina .. nal para la Salud y la Excelencia Clnica (NICE en
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® riceve indicazione preliminare positiv .. ealth and Clinical Excellence (NICE) per l'uso ne
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® erhlt die vorlufige Empfehlung des bri .. r Health and Clinical Excellence (NICE) zur Anwen
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® reoit un avis pr©alable favorable de .. et de l'excellence clinique (INEC) pour tre util
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® ontvangt positieve aanbeveling van het .. and Clinical Excellence (NICE) voor gebruik in d
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Biodel to Report First Quarter Fiscal Year 2009 R .. sults of Bioequivalence Study on February 5, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Abiomed Third Fiscal Quarter 2009 Earnings and Conference Call Notification
[ Fri, Jan 30th 2009 ] - Market Wire
Teva Announces Approval of Generic Risperdal® Oral Solution
[ Fri, Jan 30th 2009 ] - Market Wire
Daxor Corp.: Daxor Announces Tahlequah City Hospi .. lequah, OK Acquires BVA-100 Blood Volume Analyzer
[ Fri, Jan 30th 2009 ] - Market Wire
First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence
[ Fri, Jan 30th 2009 ] - Market Wire
DexCom Announces Pricing of Public Offering of Common Stock
[ Fri, Jan 30th 2009 ] - Market Wire
Health Management Associates, Inc. to Present at .. lobal High Yield and Leveraged Finance Conference
[ Fri, Jan 30th 2009 ] - Market Wire
GeneThera: Dr. Antonio Milici of GeneThera Nomina .. for National Advisory Committee on Meat & Poultry
[ Fri, Jan 30th 2009 ] - Market Wire
CONMED Corporation: CONMED Corporation to Announc .. uarter 2008 Financial Results on February 5, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
King Pharmaceuticals Announces Positive Results f .. ety and Efficacy Study of EMBEDA" Extended Releas
[ Fri, Jan 30th 2009 ] - Market Wire
Progen-Avexa Merger Update
[ Fri, Jan 30th 2009 ] - Market Wire
St. Jude Medical Announces 2009 Annual Investor Conference
[ Fri, Jan 30th 2009 ] - Market Wire
SonoSite Introduces Powerful New Turbo Technology for S Series"
[ Fri, Jan 30th 2009 ] - Market Wire
GTx Congratulates Dr. Duane D. Miller on His Indu .. Chemical Society Medicinal Chemistry Hall of Fame
[ Fri, Jan 30th 2009 ] - Market Wire
Hollis-Eden Pharmaceuticals to Present at 2009 BIO CEO and Investor Conference
[ Fri, Jan 30th 2009 ] - Market Wire
Forbes Names Illumina America?s Fastest-Growing Technology Company for Second Time
[ Fri, Jan 30th 2009 ] - Market Wire
REVLIMID® Receives Preliminary Positive Recommen .. for Health and Clinical Excellence (NICE) for Us
[ Fri, Jan 30th 2009 ] - Market Wire
Santarus Submits New Drug Application for ZEGERID Tablet Product
Thu, January 29, 2009
[ Thu, Jan 29th 2009 ] - Market Wire
EXACT Sciences Regains NASDAQ Compliance
[ Thu, Jan 29th 2009 ] - Market Wire
CompCare Acquires Core Corporate Consulting Group, Inc.
[ Thu, Jan 29th 2009 ] - Market Wire
Watson Pharmaceuticals: Watson to Host Fourth Qua .. ll Year 2008 Earnings Conference Call and Webcast
[ Thu, Jan 29th 2009 ] - Market Wire
Seattle Genetics to Host Conference Call and Webc .. ter and Year 2008 Financial Results on February 5
[ Thu, Jan 29th 2009 ] - Market Wire
Aetna Awarded $125,000 to North Carolina Non-Profits
[ Thu, Jan 29th 2009 ] - Market Wire
Aetna Awarded $857,500 to Non-Profits in Florida
[ Thu, Jan 29th 2009 ] - Market Wire
Bio-Imaging Technologies to Present at the UBS Gl .. erence on February 9, 2009 at the Waldorf Astoria
[ Thu, Jan 29th 2009 ] - Market Wire
Eurand N.V.: FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete
[ Thu, Jan 29th 2009 ] - Market Wire
Synta Pharmaceuticals to Present at the BIO CEO & Investor Conference 2009
[ Thu, Jan 29th 2009 ] - Market Wire
Humana and Wisconsin Health Information Exchange Announce Collaborative Business Program
[ Thu, Jan 29th 2009 ] - Market Wire
Data from Columbia Laboratories? Study for the Pr .. be Presented at the Society for Maternal-Fetal Me
[ Thu, Jan 29th 2009 ] - Market Wire
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2008 Financial Results
[ Thu, Jan 29th 2009 ] - Market Wire
University of Texas at Austin Acquires SOLiD System to Advance Genomic Research
[ Thu, Jan 29th 2009 ] - Market Wire
Alexion?s Soliris(R) (eculizumab) Receives Marketing Approval in Canada for All Patients with PNH
[ Thu, Jan 29th 2009 ] - Market Wire
Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs
[ Thu, Jan 29th 2009 ] - Market Wire
Transcend Reports 18% Revenue Growth, 28% Increas .. in Pre-Tax Income and Earnings Per Share of $.17
[ Thu, Jan 29th 2009 ] - Market Wire
POZEN Informed by FDA That Endoscopic Gastric Ulc .. ce Continues to Be an Acceptable Primary Endpoint
[ Thu, Jan 29th 2009 ] - Market Wire
Micrus Endovascular to Hold Fiscal 2009 Third Quarter Conference Call on February 5
Wed, January 28, 2009
[ Wed, Jan 28th 2009 ] - Market Wire
Enzon Nominates Two New Candidates for Its Board of Directors
[ Wed, Jan 28th 2009 ] - Market Wire
Aetna Announces 2009 Annual Meeting Details
[ Wed, Jan 28th 2009 ] - Market Wire
CombinatoRx Publishes Data on Selective Amplification of Synergistic Combination Drug Candidate
[ Wed, Jan 28th 2009 ] - Market Wire
Sepracor Announces Strategic Corporate Restructur .. ction Plan in Addition to 2009 Financial Guidance
[ Wed, Jan 28th 2009 ] - Market Wire
Positron Corporation?s Joint Venture Submits FDA 510(k) for its Attrius" PET Scanner
[ Wed, Jan 28th 2009 ] - Market Wire
Hansen Medical, Inc.: Hansen Medical Announces 2008 Fourth Quarter Conference Call
[ Wed, Jan 28th 2009 ] - Market Wire
Vitro Receives Notice of Allowance for Adult Stem .. rom the United States Patent and Trademark Office
[ Wed, Jan 28th 2009 ] - Market Wire
Resumen: Gilead esboza las prioridades de I+D para 2009
[ Wed, Jan 28th 2009 ] - Market Wire
Samenvatting: Gilead zet prioriteiten O&O uiteen voor 2009
[ Wed, Jan 28th 2009 ] - Market Wire
Gilead gibt Schwerpunkte fr Forschung und Entwicklung 2009 bekannt
[ Wed, Jan 28th 2009 ] - Market Wire
Synovis Life Technologies to Webcast Fiscal First .. r Earnings Conference Call Wednesday, February 25
[ Wed, Jan 28th 2009 ] - Market Wire
VIVUS Announces Senior Management Promotions
[ Wed, Jan 28th 2009 ] - Market Wire
Geron Announces John Walker Resigns as Director
[ Wed, Jan 28th 2009 ] - Market Wire
Sequenom Terminates Exchange Offer to Acquire EXACT Sciences
[ Wed, Jan 28th 2009 ] - Market Wire
Medtronic Expands CURE-AF Clinical Program into Europe and Canada
[ Wed, Jan 28th 2009 ] - Market Wire
ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 27, 2009
[ Wed, Jan 28th 2009 ] - Market Wire
U.S. FDA Approves OraQuick ADVANCE® 12-Month Shelf Life Dating
[ Wed, Jan 28th 2009 ] - Market Wire
ZymoGenetics Secures Worldwide Rights to IL-21
Tue, January 27, 2009
[ Tue, Jan 27th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Inc. Prov .. ication on Engagement of Investor Relations Group
[ Tue, Jan 27th 2009 ] - Market Wire
UnitedHealth Group/PacifiCare Awards More Than $5 .. Grants to Help Improve Health Care in California
[ Tue, Jan 27th 2009 ] - Market Wire
Cavit Sciences, Inc.: Cavit Sciences Announces Update to Shareholders
[ Tue, Jan 27th 2009 ] - Market Wire
Pioneer Behavioral Health: PHC Sets Fiscal Second .. ence Call for Friday, February 13 at 10:00 a.m. E
[ Tue, Jan 27th 2009 ] - Market Wire
UnitedHealth Group?s Evercare Business Awarded for Innovation in Coordinated Care
[ Tue, Jan 27th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Inc. Engages Investor Relations Group
[ Tue, Jan 27th 2009 ] - Market Wire
Astellas Proposes to Acquire CV Therapeutics for $16 Per Share in Cash
[ Tue, Jan 27th 2009 ] - Market Wire
Oculus Innovative Sciences Announces $3 Million I .. tner to Fund Oculus to Profitability in 12 Months
[ Tue, Jan 27th 2009 ] - Market Wire
DOR BioPharma, Inc.: DOR BioPharma Announces Appo .. pher J. Schaber, PhD, to BioNJ Board of Directors
[ Tue, Jan 27th 2009 ] - Market Wire
Alnylam Promotes Akshay Vaishnaw to Senior Vice President, Clinical Research
[ Tue, Jan 27th 2009 ] - Market Wire
St. Jude Medical Reports Fourth Quarter and Full-Year 2008 Results
[ Tue, Jan 27th 2009 ] - Market Wire
Reflect Scientific: Reflect Scientific Adds Midwest Sales Representative
[ Tue, Jan 27th 2009 ] - Market Wire
Sequenom Commences Exchange Offer to Acquire EXACT Sciences
[ Tue, Jan 27th 2009 ] - Market Wire
PhotoMedex Announces Effectiveness of 1-for-7 Reverse Stock Split
[ Tue, Jan 27th 2009 ] - Market Wire
Inspire Initiates Phase 3 Prolacria" Dry Eye Trial under Special Protocol Assessment Agreement
[ Tue, Jan 27th 2009 ] - Market Wire
Illumina Launches Suite of Next-Generation Sequencing Kits
[ Tue, Jan 27th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Onyx Pha .. wfield Exploration, D.R. Horton, KB Home and MGIC
[ Tue, Jan 27th 2009 ] - Market Wire
SCOR: SCOR sets up Zurich Hub
Mon, January 26, 2009
[ Mon, Jan 26th 2009 ] - Market Wire
Oculus Innovative Sciences Reduces Additional Cas .. ion as Company Targets Breakeven Within 12 Months
[ Mon, Jan 26th 2009 ] - jason scholder
First Stem Cell Study For Spinal Injury Approved. New Hope For Back Pain Sufferers Worldwide.
[ Mon, Jan 26th 2009 ] - Market Wire
Theravance, Inc.: Theravance Submits U.S. NDA for .. for the Treatment of Hospital-Acquired Pneumonia
[ Mon, Jan 26th 2009 ] - Market Wire
HealthSpring to Webcast Its Investor Day on February 27, 2009
[ Mon, Jan 26th 2009 ] - Market Wire
PhotoMedex Announces Results of Stockholders? Meeting
[ Mon, Jan 26th 2009 ] - Market Wire
DelSite, Inc.: DelSite, Inc. Discontinues Manufac .. DA Approval to Initiate Phase I Clinical Study fo
[ Mon, Jan 26th 2009 ] - Market Wire
Mannatech Launches Economic Stimulus Plan for Business Builders
[ Mon, Jan 26th 2009 ] - Market Wire
Seattle Genetics Receives Orphan Drug Designations for SGN-35 in the United States and Europe
[ Mon, Jan 26th 2009 ] - Market Wire
DOR BioPharma, Inc.: DOR BioPharma Announces Form .. Acute Radiation Enteritis Medical Advisory Board
[ Mon, Jan 26th 2009 ] - Market Wire
Endurance Athletes Get High-Quality Results with Low-Cal Accelerade Hydro and Endurox Restore
[ Mon, Jan 26th 2009 ] - Market Wire
St. Jude Medical Announces European CE Mark Appro .. Brain Stimulation Systems for Parkinson?s Disease
[ Mon, Jan 26th 2009 ] - Market Wire
Collaboration Between RXi Pharmaceuticals and the .. Medical School Receives a Massachusetts Life Scie
[ Mon, Jan 26th 2009 ] - Market Wire
MEDNAX 2008 Fourth Quarter Conference Call/Webcast Scheduled for February 5, 2009
[ Mon, Jan 26th 2009 ] - Market Wire
Sequenom Names Allan T. Bombard, M.D., Chief Medical Officer
[ Mon, Jan 26th 2009 ] - Market Wire
MEDIA ADVISORY: Pfizer and Wyeth to Host Live Press Conference in New York
[ Mon, Jan 26th 2009 ] - Market Wire
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
[ Mon, Jan 26th 2009 ] - Market Wire
WellCare Files 2007 Annual Report on Form 10-K
[ Mon, Jan 26th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: WellPoin .. tech, Green Mountain Coffee, Peet's and Starbucks
Sun, January 25, 2009
[ Sun, Jan 25th 2009 ] - Market Wire
Crucell N.V.: Discussions on a Combination of Crucell and Wyeth Discontinued
[ Sun, Jan 25th 2009 ] - Marc Woodard
Heal Back Pain Without Surgery - Embryonic Stem Cell Update!
Fri, January 23, 2009
[ Fri, Jan 23rd 2009 ] - Market Wire
Alcon Placed for the 11th Consecutive Year on FOR .. agazine?s List of 100 Best Companies to Work For?
[ Fri, Jan 23rd 2009 ] - Market Wire
Advanced Viral Research Corp.: Advanced Viral Ann .. f Operations Due to Inability to Secure Financing
[ Fri, Jan 23rd 2009 ] - Market Wire
Urologix to Host Its Fiscal 2009 Second Quarter Conference Call
[ Fri, Jan 23rd 2009 ] - Market Wire
NeoPharm, Inc. Announces Voluntary Delisting from NASDAQ and Deregistration of Common Stock
[ Fri, Jan 23rd 2009 ] - Market Wire
Sepracor Inc. Sets Conference Call and Webcast fo .. urth Quarter and Full-Year 2008 Operating Results
[ Fri, Jan 23rd 2009 ] - Market Wire
ImClone Systems and Bristol-Myers Squibb Update t .. ung Cancer Supplemental Biologics Application Sub
[ Fri, Jan 23rd 2009 ] - Market Wire
CLX Medical, Inc.: CLX Medical, Inc. Issues CEO C .. ith Ownership and Planned Distribution of FDA Cle
[ Fri, Jan 23rd 2009 ] - Market Wire
International Stem Cell Receives Second $1M Tranche Under $5 Million Financing
[ Fri, Jan 23rd 2009 ] - Market Wire
Alnylam Receives Clearance from FDA to Initiate P .. y with ALN-VSP for the Treatment of Liver Cancers
[ Fri, Jan 23rd 2009 ] - Market Wire
Hollis-Eden Researchers Present New Findings on M .. ancer Drug Candidate APOPTONE" (HE3235) at Americ
[ Fri, Jan 23rd 2009 ] - Market Wire
GTx Announces Conference Call to Discuss EMEA Label Changes to Fareston®
[ Fri, Jan 23rd 2009 ] - Market Wire
Centene Corporation?s Georgia Subsidiary Receives Prestigious NCQA Accreditation
[ Fri, Jan 23rd 2009 ] - Market Wire
Zacks Bull and Bear of the Day Highlights: Abbott Labs, Hubbell, Wipro, Citigroup and Infosys
Thu, January 22, 2009
[ Thu, Jan 22nd 2009 ] - Market Wire
Life Technologies Sets 4th Quarter and Full Year .. ings Release Date for Thursday, February 12, 2009
[ Thu, Jan 22nd 2009 ] - Market Wire
Cubist Pharmaceuticals Reports GAAP Diluted Net I .. ourth Quarter 2008 and GAAP Diluted Net Income of
[ Thu, Jan 22nd 2009 ] - Market Wire
OPKO Health Initiates Clinical Trial of the Aquashunt" to Treat Glaucoma
[ Thu, Jan 22nd 2009 ] - Market Wire
Proton Laboratories Inc.: Transparency - Sales - .. ton Laboratories Building on Years of Development
[ Thu, Jan 22nd 2009 ] - Market Wire
Bard to Host Earnings Conference Call on January 29, 2009
[ Thu, Jan 22nd 2009 ] - Market Wire
LifeVantage Names Network Marketing Expert Randal Wojta as Master Distributor for the Company
[ Thu, Jan 22nd 2009 ] - Market Wire
Simon Stevens Appointed Executive Vice President .. terprise-Wide Health Care Reform Engagement; Will
[ Thu, Jan 22nd 2009 ] - Market Wire
RXi Pharmaceuticals Appoints Rudolph Nisi, M.D. to Board of Directors
[ Thu, Jan 22nd 2009 ] - Market Wire
Antares Pharma Receives Milestone Payment from Teva for Pen Injector Device Filing
[ Thu, Jan 22nd 2009 ] - Market Wire
ZOLL Receives Clearance to Market New R Series BLS and R Series Plus Defibrillators
[ Thu, Jan 22nd 2009 ] - Market Wire
Ottawa Paramedic Service Awards ZOLL a Third Contract as Preferred Vendor for Defibrillators
[ Thu, Jan 22nd 2009 ] - Market Wire
OR-Live, Inc.: REMINDER: Surgical Tutorial on da Vinci(R) Anterior Pelvic Exenteration
[ Thu, Jan 22nd 2009 ] - Market Wire
Reflect Scientific: Reflect Scientific, Inc. Rece .. Design Contract for Controlled Environment System
[ Thu, Jan 22nd 2009 ] - Market Wire
Tenet Announces Preliminary Results for Fourth Quarter and Full Year 2008
[ Thu, Jan 22nd 2009 ] - Market Wire
Tenet Announces Exchange Offer for up to $1.6 Bil .. egate Principal Amount of Notes Due 2011 and 2012
[ Thu, Jan 22nd 2009 ] - Market Wire
ImmunoGen, Inc. Announces Conference Call to Disc .. Second Quarter Fiscal Year 2009 Financial Results
[ Thu, Jan 22nd 2009 ] - Market Wire
BioDelivery Sciences Files Shelf Registration
Wed, January 21, 2009
[ Wed, Jan 21st 2009 ] - Market Wire
Sernova Corp.: Sernova Corp.: Resignation of Just .. dent Board of Directors Initiates Internal Review
[ Wed, Jan 21st 2009 ] - Market Wire
Enzon Concludes Tender Offer for a Portion of Its Debt
[ Wed, Jan 21st 2009 ] - Market Wire
Molina Healthcare Provides More Definitive 2008 G .. dance within Company?s Previously Announced Range
[ Wed, Jan 21st 2009 ] - Market Wire
Ligand Announces Board of Directors Changes
[ Wed, Jan 21st 2009 ] - Market Wire
Akesis Pharmaceuticals Discontinues Sole Clinical .. Announces Intent to File for Chapter 7 Bankruptcy
[ Wed, Jan 21st 2009 ] - Market Wire
BioTime Launches New Stem Cell Lines in Anticipat .. val of Restrictions on Federal Funding of Embryon
[ Wed, Jan 21st 2009 ] - Market Wire
Iris BioTechnologies Launches Health Passport in .. ics System for Personalized and Targeted Medicine
[ Wed, Jan 21st 2009 ] - Market Wire
BioDelivery Sciences Announces Development Collaboration for Bioral Amphotericin B
[ Wed, Jan 21st 2009 ] - Market Wire
Alnylam and Collaborators at Harvard Medical Scho .. ing of Key Genes Implicated in the Transmission o
[ Wed, Jan 21st 2009 ] - Market Wire
Amedisys Sets Fourth Quarter 2008 Investor Conference Call
[ Wed, Jan 21st 2009 ] - Market Wire
Reed Tuckson, M.D., Named One of Black Enterprise .. ves in Corporate America and Featured on February
[ Wed, Jan 21st 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Announces Succ .. 4658 for Treatment of Duchenne Muscular Dystrophy
[ Wed, Jan 21st 2009 ] - Market Wire
Seattle Genetics Receives Special Protocol Assessment for SGN-35 Pivotal Trial in Hodgkin Lymphoma
[ Wed, Jan 21st 2009 ] - Market Wire
ReGen Biologics Announces Common Stock Financing .. ort Launch of Menaflex" Collagen Meniscus Implant
[ Wed, Jan 21st 2009 ] - Market Wire
Lifeline Biotechnologies, Inc. Announces Corporat .. for the Commencement of Commercialization Strate
[ Wed, Jan 21st 2009 ] - Market Wire
Neurologix Commences its Phase 2 Clinical Trial o .. fer Approach for Treatment of Parkinson?s Disease
[ Wed, Jan 21st 2009 ] - Market Wire
Abraxis BioScience Names Merck Veteran Van der Pl .. &D and Drug Development Efforts at Abraxis Health

Synta Pharmaceuticals to Present at the BIO CEO & Investor Conference 2009


//health-fitness.news-articles.net/content/2009/ .. ent-at-the-bio-ceo-investor-conference-2009.html
Published in Health and Fitness on Thursday, January 29th 2009 at 5:54 GMT, Last Modified on 2009-01-29 05:54:56 by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the BIO CEO & Investor Conference on Monday, February 9, 2009 at 3:15 pm (ET) at the Waldorf Astoria Hotel in New York.

In addition, Safi Bahcall, Ph.D., President and CEO, Synta Pharmaceuticals will be a panelist in the BIO CEO therapeutic workshop Oncology: The Forecast for the Melanoma Market—Partly Sunny or Mostly Cloudy? at 12:30 pm (ET) on Tuesday, February 10. Dr. Bahcall will discuss oxidative stress induction as a new therapeutic approach to treating melanoma and other cancers.

A live audio webcast and replay of the presentation will be available on the "Investors" section of the Company's website, [ www.syntapharma.com ]. The panel will not be webcast.

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. Synta has a partnership with GlaxoSmithKline for the joint development and commercialization of its lead investigational drug candidate, elesclomol, which is in a global, pivotal Phase 3 clinical trial for the treatment of metastatic melanoma. For more information, please visit [ www.syntapharma.com ].


Publication Contributing Sources

Similar Health and Fitness Publications
[ Fri, Jan 23rd 2009 ] - Market Wire
[ Mon, Jan 12th 2009 ] - Market Wire
[ Wed, Jan 07th 2009 ] - Market Wire
[ Tue, Dec 30th 2008 ] - Market Wire
[ Tue, Dec 23rd 2008 ] - Market Wire
[ Thu, Dec 18th 2008 ] - Market Wire
[ Fri, Dec 12th 2008 ] - Market Wire
[ Mon, Dec 08th 2008 ] - Market Wire
[ Wed, Dec 03rd 2008 ] - Market Wire
[ Tue, Dec 02nd 2008 ] - Market Wire
[ Thu, Nov 20th 2008 ] - Market Wire
[ Thu, Nov 20th 2008 ] - Market Wire